shutterstock_1572740566_nitpicker
nitpicker / Shutterstock.com
12 January 2021Big PharmaMuireann Bolger

Sanofi buys Kymab in boost to immunotherapy portfolio

Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
16 November 2016   Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.
Big Pharma
28 July 2016   Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.